This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ExxonMobil Q2 Earnings Surpass Estimates, Revenues Decline Y/Y
by Zacks Equity Research
XOM tops Q2 earnings estimates on stronger liquid production and refining margins despite revenue and price declines.
Fast-paced Momentum Stock Vermilion (VET) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Vermilion (VET) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Vista Energy Shares Fall 7% Since Reporting Q2 Earnings Miss
by Zacks Equity Research
VIST shares fall after Q2 EPS lags estimates by a wide margin despite surging output and an upgraded yearly guidance.
Vermilion Energy (VET) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Vermilion (VET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Vermilion Energy (VET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is Why Growth Investors Should Buy Vermilion (VET) Now
by Zacks Equity Research
Vermilion (VET) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Matador Resources Q2 Earnings Beat on Higher Production Volumes
by Zacks Equity Research
MTDR tops Q2 EPS estimates on record production and cost cuts despite lower oil prices and a revenue miss.
Should Value Investors Buy Vermilion Energy (VET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Looking for a Growth Stock? 3 Reasons Why Vermilion (VET) is a Solid Choice
by Zacks Equity Research
Vermilion (VET) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts See a 29.73% Upside in Vermilion (VET): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Vermilion (VET) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks Industry Outlook Highlights Vermilion Energy, VAALCO Energy and Capricorn Energy
by Zacks Equity Research
VET, EGY, and CRNCY stand out in a pressured international E&P sector with strong cash flow, value, and global exposure.
International E&P Industry: Your Guide to 3 Resilient Stocks
by Nilanjan Choudhury
Despite oil headwinds, VET, EGY and CRNCY stand out in the Zacks Oil and Gas - International E&P industry for strong cash flow and smart asset management.
Vermilion Energy to Sell Saskatchewan & Manitoba Assets for $415M
by Zacks Equity Research
VET mentions that proceeds from the asset sale are intended to strengthen the company's balance sheet and improve its financial position.
Vermilion Energy (VET) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Vermilion (VET) delivered earnings and revenue surprises of -58.82% and 3.54%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Vaalco Energy (EGY) Reports Next Week: What to Expect
by Zacks Equity Research
Vaalco Energy (EGY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Vermilion Energy (VET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Vermilion Energy (VET) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Vermilion (VET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TotalEnergies to Report Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
TTE's first-quarter earnings are likely to have benefited from its multi-energy focus. Increasing competition and currency fluctuation may offset some positives.
Vermilion (VET) Upgraded to Buy: Here's Why
by Zacks Equity Research
Vermilion (VET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Investors Undervaluing Vermilion Energy (VET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Vermilion (VET) Stock Jumps 21.2%: Will It Continue to Soar?
by Zacks Equity Research
Vermilion (VET) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Exxon Mobil and Builders FirstSource have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Exxon Mobil and Builders FirstSource are part of the Zacks Bull and Bear of the Day article.
3 Stocks to Watch That Declared Dividend Hikes Amid Market Volatility
by Ritujay Ghosh
VET, CHRD and VNOM recently announced dividend hikes.
Vermilion Energy (VET) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Vermilion (VET) delivered earnings and revenue surprises of -125% and 0.60%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Vermilion Energy (VET) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Vermilion (VET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.